Volker Kinast
Oldenburg, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Viral entry defines the hepatitis E virus species barrier in murine hepatocytes.
Journal: Emerging microbes & infections
Published: July 27, 2026
Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection.
Journal: eGastroenterology
Published: December 17, 2025
Beyond the liver: the broadened tissue tropism of hepatitis E virus.
Journal: Current opinion in virology
Published: November 05, 2025
Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture models.
Journal: Emerging microbes & infections
Published: June 27, 2025
How hepatitis E virus invades hepatocytes: the mystery of viral entry.
Journal: Trends in microbiology
Published: March 13, 2025
The tyrosine kinase Yes1 is a druggable host factor of HEV.
Journal: Hepatology communications
Published: June 24, 2024
The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.
Journal: PLoS pathogens
Published: May 09, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.
Journal: PLoS biology
Published: February 16, 2024
The relation of host genetics to symptomatic hepatitis E.
Journal: Hepatology (Baltimore, Md.)
Published: December 19, 2023
Targeting cellular cathepsins inhibits hepatitis E virus entry.
Journal: Hepatology (Baltimore, Md.)
Published: November 03, 2023
Last Updated: 09/26/2026